{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:45:50Z","timestamp":1761101150050,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":112,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781461494362"},{"type":"electronic","value":"9781461494379"}],"license":[{"start":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T00:00:00Z","timestamp":1388102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T00:00:00Z","timestamp":1388102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4614-9437-9_10","type":"book-chapter","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T19:29:16Z","timestamp":1390937356000},"page":"159-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Methods of Detection of Immune Reconstitution and T Regulatory Cells by Flow Cytometry"],"prefix":"10.1007","author":[{"given":"Richard Charles","family":"Duggleby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Alejandro","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,27]]},"reference":[{"key":"10_CR1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199501193320303","volume":"332","author":"CL Mackall","year":"1995","unstructured":"Mackall CL, Fleisher TA, Brown MR et al (1995) Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143\u2013149","journal-title":"N Engl J Med"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/00007890-200204150-00026","volume":"73","author":"J Storek","year":"2002","unstructured":"Storek J, Joseph A, Dawson MA et al (2002) Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation. Transplantation 73:1154\u20131158","journal-title":"Transplantation"},{"key":"10_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbmt.2004.12.001","volume":"11","author":"M Eyrich","year":"2005","unstructured":"Eyrich M, Wollny G, Tzaribaschev N et al (2005) Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biol Blood Marrow Transplant 11:194\u2013205","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/clim.2000.4938","volume":"97","author":"CM Steffens","year":"2000","unstructured":"Steffens CM, Al-Harthi L, Shott S et al (2000) Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and na\u00efve phenotypes. Clin Immunol 97:95\u2013101","journal-title":"Clin Immunol"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-065X.1997.tb01030.x","volume":"160","author":"CL Mackall","year":"1997","unstructured":"Mackall CL, Gress RE (1997) Thymic aging and T-cell regeneration. Immunol Rev 160:91\u2013102","journal-title":"Immunol Rev"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1016\/j.jaci.2009.11.014","volume":"125","author":"J Chinen","year":"2010","unstructured":"Chinen J, Buckley RH (2010) Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol 125:S324\u2013S335","journal-title":"J Allergy Clin Immunol"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V97.5.1458","volume":"97","author":"K Weinberg","year":"2001","unstructured":"Weinberg K (2001) Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97:1458\u20131466","journal-title":"Blood"},{"key":"10_CR8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2141.2001.03135.x","volume":"115","author":"S Maury","year":"2001","unstructured":"Maury S, Mary JY, Rabian C et al (2001) Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 115:630\u2013641","journal-title":"Br J Haematol"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V100.6.2235","volume":"100","author":"SR Lewin","year":"2002","unstructured":"Lewin SR, Heller G, Zhang L et al (2002) Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. Blood 100:2235\u20132242","journal-title":"Blood"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1182\/blood-2003-05-1428","volume":"102","author":"JF Poulin","year":"2003","unstructured":"Poulin JF, Sylvestre M, Champagne P et al (2003) Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. Blood 102:4600\u20134607","journal-title":"Blood"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1704235","volume":"32","author":"PR Fallen","year":"2003","unstructured":"Fallen PR, McGreavey L, Madrigal JA et al (2003) Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 32:1001\u20131014","journal-title":"Bone Marrow Transplant"},{"key":"10_CR12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<131::AID-AJH6>3.0.CO;2-Y","volume":"54","author":"J Storek","year":"1997","unstructured":"Storek J, Gooley T, Witherspoon RP et al (1997) Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 54:131\u2013138","journal-title":"Am J Hematol"},{"key":"10_CR13","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1073\/pnas.87.16.6301","volume":"87","author":"N Fukushi","year":"1990","unstructured":"Fukushi N, Arase H, Wang B et al (1990) Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci USA 87:6301\u20136305","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4049\/jimmunol.152.4.1609","volume":"152","author":"GA Holl\u00e4nder","year":"1994","unstructured":"Holl\u00e4nder GA, Widmer B, Burakoff SJ (1994) Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol 152:1609\u20131617","journal-title":"J Immunol"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007890-200002150-00026","volume":"69","author":"MR van den Brink","year":"2000","unstructured":"van den Brink MR, Moore E, Ferrara JL et al (2000) Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation 69:446\u2013449","journal-title":"Transplantation"},{"key":"10_CR16","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/sj.leu.2404681","volume":"21","author":"M Jim\u00e9nez","year":"2007","unstructured":"Jim\u00e9nez M, Ercilla G, Mart\u00ednez C (2007) Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia 21:1628\u20131637","journal-title":"Leukemia"},{"key":"10_CR17","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","volume":"112","author":"VK Prasad","year":"2008","unstructured":"Prasad VK, Mendizabal A, Parikh SH et al (2008) Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 112:2979\u20132989","journal-title":"Blood"},{"key":"10_CR18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bmt.1703575","volume":"29","author":"DS Allan","year":"2002","unstructured":"Allan DS, Keeney M, Howson-Jan K et al (2002) Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 29:967\u2013972","journal-title":"Bone Marrow Transplant"},{"key":"10_CR19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MOH.0b013e328353bc7d","volume":"19","author":"M Bosch","year":"2012","unstructured":"Bosch M, Khan FM, Storek J (2012) Immune reconstitution after hematopoietic cell transplantation. Curr Opin Hematol 19:324\u2013335","journal-title":"Curr Opin Hematol"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","volume":"55","author":"K Karre","year":"2002","unstructured":"Karre K (2002) NK cells, MHC class I molecules and the missing self. Scand J Immunol 55:221\u2013228","journal-title":"Scand J Immunol"},{"key":"10_CR21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.bmt.1703056","volume":"27","author":"K Fujimaki","year":"2001","unstructured":"Fujimaki K, Maruta A, Yoshida M et al (2001) Immune reconstitution assessed during five years after allogeneic bone marrow transplantation. Bone Marrow Transplant 27:1275\u20131281","journal-title":"Bone Marrow Transplant"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633\u2013640","journal-title":"Trends Immunol"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2007-05-092130","volume":"110","author":"KV Komanduri","year":"2007","unstructured":"Komanduri KV, St John LS, de Lima M et al (2007) Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 110:4543\u20134551","journal-title":"Blood"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000323661","volume":"126","author":"C De Angelis","year":"2011","unstructured":"De Angelis C, Mancusi A, Ruggeri L et al (2011) Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. Acta Haematol 126:13\u201320","journal-title":"Acta Haematol"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bbmt.2008.04.013","volume":"14","author":"LF Porrata","year":"2008","unstructured":"Porrata LF, Inwards DJ, Ansell SM et al (2008) Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol Blood Marrow Transplant 14:807\u2013816","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbmt.2007.12.497","volume":"14","author":"YJ Chang","year":"2008","unstructured":"Chang YJ, Zhao XY, Huang XJ (2008) Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies. Biol Blood Marrow Transplant 14:323\u2013334","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR27","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2004-04-1506","volume":"104","author":"F Baron","year":"2004","unstructured":"Baron F, Baker JE, Storb R et al (2004) Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 104:2254\u20132262","journal-title":"Blood"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2007.11.013","volume":"127","author":"A Marie-Cardine","year":"2008","unstructured":"Marie-Cardine A, Divay F, Dutot I et al (2008) Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 127:14\u201325","journal-title":"Clin Immunol"},{"key":"10_CR29","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4049\/jimmunol.1000879","volume":"185","author":"JM Sugalski","year":"2010","unstructured":"Sugalski JM, Rodriguez B, Moir S et al (2010) Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection. J Immunol 185:3019\u20133027","journal-title":"J Immunol"},{"key":"10_CR30","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","volume":"97","author":"J Storek","year":"2001","unstructured":"Storek J (2001) Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97:3380\u20133389","journal-title":"Blood"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.V89.1.350","volume":"89","author":"J Storek","year":"1997","unstructured":"Storek J, Witherspoon RP, Storb R (1997) Reconstitution of membrane IgD- (mIgD-) B cells after marrow transplantation lags behind the reconstitution of mIgD+ B cells. Blood 89:350\u2013351","journal-title":"Blood"},{"key":"10_CR32","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/00007890-200212150-00012","volume":"74","author":"N Novitzky","year":"2002","unstructured":"Novitzky N, Davison GM, Hale G et al (2002) Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 74:1551\u20131559","journal-title":"Transplantation"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1182\/blood.V96.9.3290","volume":"96","author":"J Storek","year":"2000","unstructured":"Storek J, Espino G, Dawson MA et al (2000) Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation. Blood 96:3290\u20133293","journal-title":"Blood"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V98.2.489","volume":"98","author":"J Storek","year":"2001","unstructured":"Storek J, Wells D, Dawson MA et al (2001) Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 98:489\u2013491","journal-title":"Blood"},{"key":"10_CR35","first-page":"2208","volume":"94","author":"RE Curtis","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA et al (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94:2208\u20132216","journal-title":"Blood"},{"key":"10_CR36","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V66.3.664.664","volume":"66","author":"PJ Martin","year":"1985","unstructured":"Martin PJ, Hansen JA, Buckner CD et al (1985) Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664\u2013672","journal-title":"Blood"},{"key":"10_CR37","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","volume":"78","author":"AM Marmont","year":"1991","unstructured":"Marmont AM, Horowitz MM, Gale RP et al (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120\u20132130","journal-title":"Blood"},{"key":"10_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbmt.2012.10.010","volume":"19","author":"IH Bartelink","year":"2013","unstructured":"Bartelink IH, Belitser SV, Knibbe CAJ et al (2013) Immune reconstitution kinetics as an early predictor for mortality using various hematopoietic stem cell sources in children. Biol Blood Marrow Transplant 19:305\u2013313","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR39","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745\u2013763","journal-title":"Annu Rev Immunol"},{"key":"10_CR40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4049\/jimmunol.150.3.1105","volume":"150","author":"LJ Picker","year":"1993","unstructured":"Picker LJ, Treer JR, Ferguson-Darnell B et al (1993) Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selectin on T cells during the virgin to memory cell transition. J Immunol 150:1105\u20131121","journal-title":"J Immunol"},{"key":"10_CR41","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V98.13.3505","volume":"98","author":"J Storek","year":"2001","unstructured":"Storek J, Joseph A, Espino G et al (2001) Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 98:3505\u20133512","journal-title":"Blood"},{"key":"10_CR42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20011756","volume":"195","author":"S Kimmig","year":"2002","unstructured":"Kimmig S, Przybylski GK, Schmidt CA et al (2002) Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 195:789\u2013794","journal-title":"J Exp Med"},{"key":"10_CR43","first-page":"413","volume":"16","author":"J Storek","year":"1995","unstructured":"Storek J, Witherspoon RP, Storb R (1995) T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 16:413\u2013425","journal-title":"Bone Marrow Transplant"},{"key":"10_CR44","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V98.5.1358","volume":"98","author":"JW Gratama","year":"2001","unstructured":"Gratama JW, van Esser JW, Lamers CH et al (2001) Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98:1358\u20131364","journal-title":"Blood"},{"key":"10_CR45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbmt.2010.04.011","volume":"17","author":"D Pastore","year":"2011","unstructured":"Pastore D, Delia M, Mestice A et al (2011) Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 17:550\u2013557","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2004.05331.x","volume":"128","author":"T Feuchtinger","year":"2005","unstructured":"Feuchtinger T, L\u00fccke J, Hamprecht K et al (2005) Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 128:503\u2013509","journal-title":"Br J Haematol"},{"key":"10_CR47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531\u2013562","journal-title":"Annu Rev Immunol"},{"key":"10_CR48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux H, O\u2019Garra A, Bigler M et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737\u2013742","journal-title":"Nature"},{"key":"10_CR49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-065X.2001.1820117.x","volume":"182","author":"HL Weiner","year":"2001","unstructured":"Weiner HL (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182:207\u2013214","journal-title":"Immunol Rev"},{"key":"10_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","volume":"117","author":"C Dejaco","year":"2006","unstructured":"Dejaco C, Duftner C, Grubeck-Loebenstein B et al (2006) Imbalance of regulatory T cells in human autoimmune diseases. Immunology 117:289\u2013300","journal-title":"Immunology"},{"key":"10_CR51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1286-4579(02)01574-5","volume":"4","author":"O Annacker","year":"2002","unstructured":"Annacker O, Powrie F (2002) Homeostasis of intestinal immune regulation. Microbes Infect 4:567\u2013574","journal-title":"Microbes Infect"},{"key":"10_CR52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20020556","volume":"196","author":"MC Kullberg","year":"2002","unstructured":"Kullberg MC, Jankovic D, Gorelick PL et al (2002) Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196:505\u2013515","journal-title":"J Exp Med"},{"key":"10_CR53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.20021345","volume":"197","author":"KJ Maloy","year":"2003","unstructured":"Maloy KJ, Salaun L, Cahill R et al (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197:111\u2013119","journal-title":"J Exp Med"},{"key":"10_CR54","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#","volume":"32","author":"S Hori","year":"2002","unstructured":"Hori S, Carvalho TL, Demengeot J (2002) CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32:1282\u20131291","journal-title":"Eur J Immunol"},{"key":"10_CR55","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.169.11.6298","volume":"169","author":"C Montagnoli","year":"2002","unstructured":"Montagnoli C, Bacci A, Bozza S et al (2002) B7\/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 169:6298\u20136308","journal-title":"J Immunol"},{"key":"10_CR56","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.4049\/jimmunol.169.6.3232","volume":"169","author":"A Aseffa","year":"2002","unstructured":"Aseffa A, Gumy A, Launois P et al (2002) The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB\/c mice are subject to the control of regulatory CD4+CD25+ T cells. J Immunol 169:3232\u20133241","journal-title":"J Immunol"},{"key":"10_CR57","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","volume":"420","author":"Y Belkaid","year":"2002","unstructured":"Belkaid Y, Piccirillo CA, Mendez S et al (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502\u2013507","journal-title":"Nature"},{"key":"10_CR58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni1317","volume":"7","author":"J Trowsdale","year":"2006","unstructured":"Trowsdale J, Betz AG (2006) Mother\u2019s little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 7:241\u2013246","journal-title":"Nat Immunol"},{"key":"10_CR59","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","volume":"117","author":"M Di Ianni","year":"2011","unstructured":"Di Ianni M, Falzetti F, Carotti A et al (2011) Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117:3921\u20133928","journal-title":"Blood"},{"key":"10_CR60","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","volume":"117","author":"CG Brunstein","year":"2011","unstructured":"Brunstein CG, Miller JS, Cao Q et al (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117:1061\u20131070","journal-title":"Blood"},{"key":"10_CR61","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151\u20131164","journal-title":"J Immunol"},{"key":"10_CR62","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","volume":"203","author":"N Seddiki","year":"2006","unstructured":"Seddiki N, Santner-Nanan B, Martinson J et al (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203:1693\u20131700","journal-title":"J Exp Med"},{"key":"10_CR63","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330\u2013336","journal-title":"Nat Immunol"},{"key":"10_CR64","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061","journal-title":"Science"},{"key":"10_CR65","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko S-A et al (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337\u2013342","journal-title":"Nat Immunol"},{"key":"10_CR66","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0509484103","volume":"103","author":"MA Gavin","year":"2006","unstructured":"Gavin MA, Torgerson TR, Houston E et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103:6659\u20136664","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR67","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/01.tp.0000260140.04815.77","volume":"83","author":"D Wolf","year":"2007","unstructured":"Wolf D, Wolf AM, Fong D et al (2007) Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation 83:1107\u20131113","journal-title":"Transplantation"},{"key":"10_CR68","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood-2006-02-003996","volume":"108","author":"K Rezvani","year":"2006","unstructured":"Rezvani K, Mielke S, Ahmadzadeh M et al (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108:1291\u20131297","journal-title":"Blood"},{"issue":"3","key":"10_CR69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3324\/haematol.2012.072991","volume":"98","author":"Z McIver","year":"2013","unstructured":"McIver Z, Melenhorst JJ, Wu C et al (2013) Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant. Haematologica 98(3):346\u2013352","journal-title":"Haematologica"},{"key":"10_CR70","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-065X.2008.00634.x","volume":"223","author":"SE Allan","year":"2008","unstructured":"Allan SE, Broady R, Gregori S et al (2008) CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 223:391\u2013421","journal-title":"Immunol Rev"},{"key":"10_CR71","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2003-06-2073","volume":"103","author":"FJ Clark","year":"2004","unstructured":"Clark FJ, Gregg R, Piper K et al (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood 103:2410\u20132416","journal-title":"Blood"},{"key":"10_CR72","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2141.2004.05108.x","volume":"126","author":"J Sanchez","year":"2004","unstructured":"Sanchez J, Casa\u00f1o J, Alvarez MA et al (2004) Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 126:697\u2013703","journal-title":"Br J Haematol"},{"key":"10_CR73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1751-553X.2011.01300.x","volume":"33","author":"N Watanabe","year":"2011","unstructured":"Watanabe N, Narita M, Furukawa T et al (2011) Kinetics of pDCs, mDCs, \u03b3\u03b4T cells and regulatory T cells in association with graft versus host disease after hematopoietic stem cell transplantation. Int J Lab Hematol 33:378\u2013390","journal-title":"Int J Lab Hematol"},{"key":"10_CR74","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbmt.2010.02.026","volume":"16","author":"JM Magenau","year":"2010","unstructured":"Magenau JM, Qin X, Tawara I et al (2010) Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease. Biol Blood Marrow Transplant 16:907\u2013914","journal-title":"Biol Blood Marrow Transplant"},{"key":"10_CR75","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","volume":"106","author":"E Zorn","year":"2005","unstructured":"Zorn E, Kim HT, Lee SJ et al (2005) Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 106:2903\u20132911","journal-title":"Blood"},{"key":"10_CR76","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.exphem.2005.05.001","volume":"33","author":"V Meignin","year":"2005","unstructured":"Meignin V, Peffault de Latour R, Zuber J et al (2005) Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation. Exp Hematol 33:894\u2013900","journal-title":"Exp Hematol"},{"key":"10_CR77","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2011-06-362137","volume":"118","author":"Y Kawano","year":"2011","unstructured":"Kawano Y, Kim HT, Matsuoka KI et al (2011) Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation. Blood 118:5021\u20135030","journal-title":"Blood"},{"key":"10_CR78","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2004-03-1040","volume":"104","author":"Y Miura","year":"2004","unstructured":"Miura Y, Thoburn CJ, Bright EC et al (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104:2187\u20132193","journal-title":"Blood"},{"key":"10_CR79","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12185-011-0976-7","volume":"95","author":"AM Ngoma","year":"2012","unstructured":"Ngoma AM, Ikeda K, Hashimoto Y et al (2012) Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation. Int J Hematol 95:86\u201394","journal-title":"Int J Hematol"},{"key":"10_CR80","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1182\/blood-2007-03-079160","volume":"110","author":"S Mielke","year":"2007","unstructured":"Mielke S, Rezvani K, Savani BN et al (2007) Reconstitution of FOXP3. Blood 110:1689\u20131697","journal-title":"Blood"},{"key":"10_CR81","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","volume":"107","author":"K Rieger","year":"2006","unstructured":"Rieger K, Loddenkemper C, Maul J et al (2006) Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107:1717\u20131723","journal-title":"Blood"},{"key":"10_CR82","first-page":"3593","volume":"8","author":"KN Wu","year":"2009","unstructured":"Wu KN, Emmons RVB, Lisanti MP et al (2009) Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin. Cell Cycle 8:3593\u20133597","journal-title":"Cell Cycle"},{"key":"10_CR83","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1182\/blood-2011-11-364091","volume":"119","author":"EO Stenger","year":"2012","unstructured":"Stenger EO, Turnquist HR, Mapara MY et al (2012) Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity. Blood 119:5088\u20135103","journal-title":"Blood"},{"key":"10_CR84","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.immuni.2007.06.006","volume":"26","author":"L Wu","year":"2007","unstructured":"Wu L, Liu YJ (2007) Development of dendritic-cell lineages. Immunity 26:741\u2013750","journal-title":"Immunity"},{"key":"10_CR85","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","volume":"8","author":"M Gilliet","year":"2008","unstructured":"Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8:594\u2013606","journal-title":"Nat Rev Immunol"},{"key":"10_CR86","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1182\/blood-2008-07-168609","volume":"113","author":"M Koyama","year":"2009","unstructured":"Koyama M, Hashimoto D, Aoyama K et al (2009) Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells. Blood 113:2088\u20132095","journal-title":"Blood"},{"key":"10_CR87","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","volume":"165","author":"A Dzionek","year":"2000","unstructured":"Dzionek A, Fuchs A, Schmidt P et al (2000) BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165:6037\u20136046","journal-title":"J Immunol"},{"key":"10_CR88","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","volume":"285","author":"WD Shlomchik","year":"1999","unstructured":"Shlomchik WD, Couzens MS, Tang CB et al (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285:412\u2013415","journal-title":"Science"},{"key":"10_CR89","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.4049\/jimmunol.172.12.7393","volume":"172","author":"UA Duffner","year":"2004","unstructured":"Duffner UA, Maeda Y, Cooke KR et al (2004) Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 172:7393\u20137398","journal-title":"J Immunol"},{"key":"10_CR90","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm1089","volume":"10","author":"CC Matte","year":"2004","unstructured":"Matte CC, Liu J, Cormier J et al (2004) Donor APCs are required for maximal GVHD but not for GVL. Nat Med 10:987\u2013992","journal-title":"Nat Med"},{"key":"10_CR91","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nm1309","volume":"11","author":"P Reddy","year":"2005","unstructured":"Reddy P, Maeda Y, Liu C et al (2005) A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 11:1244\u20131249","journal-title":"Nat Med"},{"key":"10_CR92","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-03-007427","volume":"108","author":"R Chakraverty","year":"2006","unstructured":"Chakraverty R, Eom HS, Sachs J et al (2006) Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions. Blood 108:2106\u20132113","journal-title":"Blood"},{"key":"10_CR93","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2003-09-3325","volume":"103","author":"V Reddy","year":"2004","unstructured":"Reddy V, Iturraspe JA, Tzolas AC et al (2004) Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 103:4330\u20134335","journal-title":"Blood"},{"key":"10_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2403558","volume":"19","author":"M Mohty","year":"2005","unstructured":"Mohty M, Blaise D, Faucher C et al (2005) Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation. Leukemia 19:1\u20136","journal-title":"Leukemia"},{"key":"10_CR95","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.TP.0000041783.34083.11","volume":"75","author":"FJ Clark","year":"2003","unstructured":"Clark FJ, Freeman L, Dzionek A et al (2003) Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease. Transplantation 75:221\u2013225","journal-title":"Transplantation"},{"key":"10_CR96","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood.V97.10.2948","volume":"97","author":"EK Waller","year":"2001","unstructured":"Waller EK, Rosenthal H, Jones TW et al (2001) Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 97:2948\u20132956","journal-title":"Blood"},{"key":"10_CR97","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.tp.0000258731.38149.61","volume":"83","author":"J Lau","year":"2007","unstructured":"Lau J, Sartor M, Bradstock KF et al (2007) Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease. Transplantation 83:839\u2013846","journal-title":"Transplantation"},{"key":"10_CR98","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2004-10-3927","volume":"105","author":"YR Lee","year":"2005","unstructured":"Lee YR, Yang IH, Lee YH et al (2005) Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood 105:3951\u20133955","journal-title":"Blood"},{"key":"10_CR99","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.4049\/jimmunol.162.11.6473","volume":"162","author":"L Piemonti","year":"1999","unstructured":"Piemonti L, Monti P, Allavena P et al (1999) Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162:6473\u20136481","journal-title":"J Immunol"},{"key":"10_CR100","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.4049\/jimmunol.179.9.5711","volume":"179","author":"YH Lee","year":"2007","unstructured":"Lee YH, Lee YR, Im S et al (2007) Calcineurin inhibitors block MHC-restricted antigen presentation in vivo. J Immunol 179:5711\u20135716","journal-title":"J Immunol"},{"key":"10_CR101","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","volume":"178","author":"HR Turnquist","year":"2007","unstructured":"Turnquist HR, Raimondi G, Zahorchak AF et al (2007) Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 178:7018\u20137031","journal-title":"J Immunol"},{"issue":"5","key":"10_CR112","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2310\/6650.2001.33789","volume":"49","author":"G Szabo","year":"2001","unstructured":"Szabo G, Gavala C, Mandrekar P (2001) Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J investig med 49(5):442\u2013449","journal-title":"J investig med"},{"key":"10_CR102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","volume":"5","author":"DR Sutherland","year":"1996","unstructured":"Sutherland DR, Anderson L, Keeney M et al (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 5:213\u2013226","journal-title":"J Hematother"},{"key":"10_CR103","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/14653240902923161","volume":"11","author":"DR Sutherland","year":"2009","unstructured":"Sutherland DR, Nayyar R, Acton E et al (2009) Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy 11:595\u2013605","journal-title":"Cytotherapy"},{"key":"10_CR104","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-3083.2006.01883.x","volume":"65","author":"E Takahashi","year":"2007","unstructured":"Takahashi E, Kuranaga N, Satoh K et al (2007) Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK cells but also from CD16- CD56dim NK cells. Scand J Immunol 65:126\u2013138","journal-title":"Scand J Immunol"},{"key":"10_CR105","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.exphem.2005.12.012","volume":"34","author":"AM Barbui","year":"2006","unstructured":"Barbui AM, Borleri G, Conti E et al (2006) Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells. Exp Hematol 34:475\u2013485","journal-title":"Exp Hematol"},{"key":"10_CR106","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/icb.2009.108","volume":"88","author":"S Tanaskovic","year":"2010","unstructured":"Tanaskovic S, Fernandez S, Price P et al (2010) CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or gammadelta T-cells, in HIV patients responding to ART. Immunol Cell Biol 88:321\u2013327","journal-title":"Immunol Cell Biol"},{"key":"10_CR107","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2001-11-0097","volume":"100","author":"KPA MacDonald","year":"2002","unstructured":"MacDonald KPA, Munster DJ, Clark GJ et al (2002) Characterization of human blood dendritic cell subsets. Blood 100:4512\u20134520","journal-title":"Blood"},{"key":"10_CR110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","volume":"12","author":"HT Maecker","year":"2012","unstructured":"Maecker HT, McCoy JP, Nussenblatt R (2012) Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol 12:191\u2013200","journal-title":"Nat Rev Immunol"},{"key":"10_CR108","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/blood-2009-03-208355","volume":"114","author":"MA Pulsipher","year":"2009","unstructured":"Pulsipher MA, Chitphakdithai P, Logan BR et al (2009) Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood 114:2606\u20132616","journal-title":"Blood"},{"key":"10_CR109","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","volume":"100","author":"JE Wagner","year":"2002","unstructured":"Wagner JE, Barker JN, DeFor TE et al (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611\u20131618","journal-title":"Blood"},{"key":"10_CR111","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1172\/JCI5201E1","volume":"103","author":"B Haynes","year":"1999","unstructured":"Haynes B, Hale L, Weinhold K et al (1999) Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 103:921","journal-title":"J Clin Invest"}],"container-title":["Methods in Molecular Biology","Bone Marrow and Stem Cell Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-9437-9_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T04:17:07Z","timestamp":1674533827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4614-9437-9_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,27]]},"ISBN":["9781461494362","9781461494379"],"references-count":112,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-9437-9_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2013,12,27]]},"assertion":[{"value":"27 December 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}